Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer.

Saved in:
Bibliographic Details
Title: Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer.
Authors: Rodríguez-Casanova A; Cancer Epigenomics, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.; Translational Medical Oncology Group (Oncomet), Roche-Chus Joint Unit, Health Research Institute of Santiago (IDIS), 15706 Santiago de Compostela, Spain.; Universidade de Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain., Bao-Caamano A; Cancer Epigenomics, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.; Universidade de Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain., Lago-Lestón RM; Translational Medical Oncology Group (Oncomet), Liquid Biopsy Analysis Unit, Health Research Institute of Santiago (IDIS), 15706 Santiago de Compostela, Spain., Brozos-Vázquez E; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain., Costa-Fraga N; Cancer Epigenomics, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.; Universidade de Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain., Ferreirós-Vidal I; Translational Medical Oncology Group (Oncomet), Liquid Biopsy Analysis Unit, Health Research Institute of Santiago (IDIS), 15706 Santiago de Compostela, Spain., Abdulkader I; Department of Pathology, University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain., Vidal-Insua Y; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain., Rivera FV; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain., Candamio Folgar S; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain., López-López R; Translational Medical Oncology Group (Oncomet), Roche-Chus Joint Unit, Health Research Institute of Santiago (IDIS), 15706 Santiago de Compostela, Spain.; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain., Muinelo-Romay L; Translational Medical Oncology Group (Oncomet), Liquid Biopsy Analysis Unit, Health Research Institute of Santiago (IDIS), 15706 Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain., Diaz-Lagares A; Cancer Epigenomics, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.
Source: Journal of clinical medicine [J Clin Med] 2021 Sep 29; Vol. 10 (19). Date of Electronic Publication: 2021 Sep 29.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34640513
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rodríguez-Casanova+A%22">Rodríguez-Casanova A</searchLink>; Cancer Epigenomics, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.; Translational Medical Oncology Group (Oncomet), Roche-Chus Joint Unit, Health Research Institute of Santiago (IDIS), 15706 Santiago de Compostela, Spain.; Universidade de Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Bao-Caamano+A%22">Bao-Caamano A</searchLink>; Cancer Epigenomics, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.; Universidade de Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Lago-Lestón+RM%22">Lago-Lestón RM</searchLink>; Translational Medical Oncology Group (Oncomet), Liquid Biopsy Analysis Unit, Health Research Institute of Santiago (IDIS), 15706 Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Brozos-Vázquez+E%22">Brozos-Vázquez E</searchLink>; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Costa-Fraga+N%22">Costa-Fraga N</searchLink>; Cancer Epigenomics, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.; Universidade de Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Ferreirós-Vidal+I%22">Ferreirós-Vidal I</searchLink>; Translational Medical Oncology Group (Oncomet), Liquid Biopsy Analysis Unit, Health Research Institute of Santiago (IDIS), 15706 Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Abdulkader+I%22">Abdulkader I</searchLink>; Department of Pathology, University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Vidal-Insua+Y%22">Vidal-Insua Y</searchLink>; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Rivera+FV%22">Rivera FV</searchLink>; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Candamio+Folgar+S%22">Candamio Folgar S</searchLink>; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22López-López+R%22">López-López R</searchLink>; Translational Medical Oncology Group (Oncomet), Roche-Chus Joint Unit, Health Research Institute of Santiago (IDIS), 15706 Santiago de Compostela, Spain.; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Muinelo-Romay+L%22">Muinelo-Romay L</searchLink>; Translational Medical Oncology Group (Oncomet), Liquid Biopsy Analysis Unit, Health Research Institute of Santiago (IDIS), 15706 Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Diaz-Lagares+A%22">Diaz-Lagares A</searchLink>; Cancer Epigenomics, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101606588%22">Journal of clinical medicine</searchLink> [J Clin Med] 2021 Sep 29; Vol. 10 (19). <i>Date of Electronic Publication: </i>2021 Sep 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101606588 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2077-0383 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220770383%22">20770383 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Med <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34640513
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/jcm10194487
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Casanova A
      – PersonEntity:
          Name:
            NameFull: Bao-Caamano A
      – PersonEntity:
          Name:
            NameFull: Lago-Lestón RM
      – PersonEntity:
          Name:
            NameFull: Brozos-Vázquez E
      – PersonEntity:
          Name:
            NameFull: Costa-Fraga N
      – PersonEntity:
          Name:
            NameFull: Ferreirós-Vidal I
      – PersonEntity:
          Name:
            NameFull: Abdulkader I
      – PersonEntity:
          Name:
            NameFull: Vidal-Insua Y
      – PersonEntity:
          Name:
            NameFull: Rivera FV
      – PersonEntity:
          Name:
            NameFull: Candamio Folgar S
      – PersonEntity:
          Name:
            NameFull: López-López R
      – PersonEntity:
          Name:
            NameFull: Muinelo-Romay L
      – PersonEntity:
          Name:
            NameFull: Diaz-Lagares A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 09
              Text: 2021 Sep 29
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2077-0383
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 19
          Titles:
            – TitleFull: Journal of clinical medicine
              Type: main
ResultId 1